Skip to main content
. 2017 Dec 12;9(1):969–981. doi: 10.18632/oncotarget.22867

Table 1. Summary of clinical features.

Underlying disease
UC 58 (64%)
CD 32 (36%)
Sex
Male 56 (62%)
Female 34 (38%)
Age at cancer diagnosis
Median (range) 49 (27–79)
Age at IBD onset
Median (range) 28 (11–67)
Duration of IBD
Median (range) 17.8 yrs (0.2–40.5)
Stage
0 4 (4%)
I 13 (14%)
II 36 (40%)
III 26 (29%)
IV 6 (7%)
NA 5 (6%)